The first product to market, Exubera by Pfizer, was withdrawn in 2007 because of this and
several other companies shutdown their late - stage trials in response.
Several microfinance
companies were in March and April this year
shutdown by the regulator while some 30
others have been hauled before the Economic and Organised Crime Office.